Texto & Contexto Enfermagem ISSN: Universidade Federal de Santa Catarina Brasil

Size: px
Start display at page:

Download "Texto & Contexto Enfermagem ISSN: Universidade Federal de Santa Catarina Brasil"

Transcription

1 Texto & Contexto Enfermagem ISSN: Universidade Federal de Santa Catarina Brasil Miotto Wright, Maria da Gloria; Cumsille, Francisco; Padilha, Maria Itayra; Arena Ventura, Carla; Sapag, Jaime; Brands, Bruna; Hamilton, Hayley; Mann, Robert; Khenti, Akwatu International research capacity building program for health related professionals to study the drug phenomenon in Latin America and the Caribbean Texto & Contexto Enfermagem, vol. 24, 2015, pp Universidade Federal de Santa Catarina Santa Catarina, Brasil Available in: How to cite Complete issue More information about this article Journal's homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative

2 Artigo Original INTERNATIONAL RESEARCH CAPACITY BUILDING PROGRAM FOR HEALTH RELATED PROFESSIONALS TO STUDY THE DRUG PHENOMENON IN LATIN AMERICA AND THE CARIBBEAN Maria da Gloria Miotto Wright 1, Francisco Cumsille 2, Maria Itayra Padilha 3, Carla Arena Ventura 4, Jaime Sapag 5, Bruna Brands 6, Hayley Hamilton 7, Robert Mann 8, Akwatu Khenti 9 1 Ph.D. Former Coordinator Educational Development Program. Interamerican Drug Abuse Control Commission (CICAD), Secretariat for Multidimensional Security. Washington, USA. gloriamiottowright@gmail.com 2 Ph.D. Head of Interamerican Drug Observatory CICAD, OAS. Washington, USA. fcumsille@oas.org 3 Ph.D. Academic Coordinator of the OAS, Secretariat for Multidimensional Security (SMS), CICAD, Centre for Addiction and Mental Health, (CAMH) International Research Capacity Building Program from 2009 to Dean and Associate Professor of Nursing Department, Federal University of Santa Catarina, Florianópolis, Brazil. itayra.padilha@ufsc.br 4 Ph.D. Academic Coordinator of the OAS/SMS/CICAD-CAMH International Research Capacity Building Program in 2014, Associate Professor at the University of São Paulo at Ribeirao Preto, School of Nursing, Brazil. caaventu@eerp.usp.br 5 Ph.D. Former Scholar of Transformative Global Health Office, CAMH. Toronto, Canada. jaimesapag@camh.ca 6 Ph.D. Senior Scientist. Office of Research and Surveillance, Drug Strategy and Controlled Substances Programme, Health Canada and Public Health and Regulatory Policies CAMH, University of Toronto, Canada. bruna.brands@camh.ca 7 Ph.D. Investigator. CAMH, University of Toronto. Toronto, Canada. hayley.hamilton@camh.ca 8 Ph.D. Investigator. CAMH, University of Toronto. Toronto, Canada. robert.mann@camh.ca 9 Doctor Student. Director, Transformative Global Health Office, CAMH. Toronto, Canada. akwatu.khenti@camh.ca ABSTRACT: Most Organization of American States member states do not have a cadre of professionals with scientific knowledge and research experience on drugs and related problems. Therefore, the Organization of American States started a partnership, first with the University of Alberta/Canada and then with the Centre for Addiction and Mental Health in Toronto/Canada to train health related professionals to address this problem. The objective is to create a cadre of health and related professionals with scientific and technical research knowledge to enable scientific advances in the area of drug demand reduction. The program requires the development and implementation of a multicentric drug research proposal. The program has produced the following results: nine multicentric drug research studies implemented in 22 countries of Latin America and the Caribbean; 91 participants from 22 countries of Latin America and the Caribbean. This is the only program in the Americas offering continued advanced research training to university faculty and contributing to strengthen the undergraduate and graduates curriculum on drug issues and research capability in Latin America and the Caribbean. DESCRIPTORS: Narcotics. Research. Capacity building. Latin America. Caribbean. PROGRAMA INTERNACIONAL DE CAPACITAÇÃO EM PESQUISA PARA PROFISSIONAIS DE SAÚDE SOBRE O ESTUDO DO FENÔMENO DAS DROGAS NA AMÉRICA LATINA E CARIBE RESUMO: A maioria dos países membros da Organização dos Estados Americanos não possui um conjunto de profissionais com experiência em pesquisa e conhecimento científico sobre drogas e problemas relacionados. Assim, a Organização dos Estados Americanos iniciou uma parceria, primeiro com a Universidade de Alberta/Canada, e depois, com o Centro de Adição e Saúde Mental em Toronto/ Canada, para capacitar profissionais das áreas relacionadas a saúde para desenvolverem pesquisas sobre o problema das drogas. O programa tem o objetivo de criar um grupo de profissionais de áreas relacionadas à saúde, com conhecimento científico e técnico em pesquisa, para favorecer avanços científicos na área de redução da demanda de drogas. O programa exige o desenvolvimento e implementação de uma proposta multicêntrica de pesquisa sobre drogas. O programa tem produzido os seguintes resultados: nove estudos multicêntricos de pesquisa sobre drogas desenvolvidos em 22 países da América Latina e Caribe e 91 participantes de 22 países de América Latina y Caribe. Este é o único programa das Américas que oferece contínuo treinamento em pesquisa avançada para professores de universidades, além de contribuir para fortalecer os currículos dos cursos de graduação e pós-graduação em questões relacionadas às drogas e a capacidade de pesquisa na America Latina e Caribe. DESCRITORES: Entorpecentes. Pesquisa. Fortalecimento institucional. América Latina. Caribe.

3 Wright MGM, Cumsille F, Padilha MI, Ventura CA, Sapag J, Brands B, et al. PROGRAMA INTERNACIONAL DE CAPACITACIÓN EN INVESTIGACIÓN PARA PROFESIONALES DE SALUD EN EL ESTUDIO DEL FENÓMENO DE LAS DROGAS EN AMÉRICA LATINA Y CARIBE RESUMEN: La mayoría de los países miembros de la Organización de los Estados Americanos no tienen un grupo de profesionales con experiencia en investigación y conocimiento científico en drogas y problemas relacionados. Así, la Organización de los Estados Americanos empezó, una asociación, primero con la Universidad de Alberta/Canadá y después con el Centro de Adición y Salud Mental en Toronto/Canadá para capacitar profesionales de áreas relacionadas a la salud para desarrollaren investigaciones sobre el problema de drogas. El programa tiene el objetivo de crear un grupo de profesionales de áreas relacionadas de la salud con conocimiento científico y técnico en investigación para favorecer los avances científicos en el área de reducción de la demanda de drogas. El programa requiere el desarrollo e implementación de una propuesta multicentrica de investigación sobre drogas. El programa tiene producido los siguientes resultados: nueve estudios multicentricos de investigación sobre drogas desarrollados en 22 países de América Latina y Caribe; 91 participantes de 22 países de América Latina y Caribe. Este es el único programa en las Américas que oferta continuamente el entrenamiento en investigación avanzada para profesores universitarios y contribuye para fortalecer los currículos de los cursos de pregrado y post grado en cuestiones sobre drogas y la capacidad de investigación en América Latina y Caribe. DESCRIPTORES: Narcóticos. Investigación. Creación de capacidad. América Latina. Caribe. INTRODUCTION Illicit drug use is one of the top twenty global health risk factors a problem which affects approximately 210 million people annually, with a related mortality rate of nearly 200, Issues stemming from the drug phenomenon include drug-related health problems, organized crime, violence and other social and economic problems. 1 The drug phenomenon has become a complex, dynamic and multi-causal problem that presents a difficult challenge to States and their governments around the world. This phenomenon demands a comprehensive, balanced and multidisciplinary approach with a shared responsibility among those involved. Drug policies for the hemisphere should focus not only on supply and control, but also on drug dependence. This new strategy explicitly recognizes that drug dependence is a chronic disease not unlike diabetes, hypertension or asthma all of which requires proper medical care to address various symptoms, as well as treat the underlying causes. Therefore, the new strategy recommends that drug dependence must be addressed as a core element of public health policy. 2 A new and improved paradigm is required to address the underlying causes of the drug phenomenon in the States. This paradigm should focus on three main goals: (a) treating drug use as a matter of public health, (b) reducing drug consumption through information, education and prevention, and (c) repressing organized crime. 3 Considering the need for innovative approaches to deal with the drug phenomenon in the Americas, the purpose of this paper is to describe the collaboration between the Inter-American Drug Control Commission (CICAD) and the Center for Addiction and Mental Health (CAMH) to implement the International Research Capacity Building Program for Health Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean. JUSTIFICATION The challenges imposed by the drug phenomenon require the formulation of partnerships and innovative approaches towards educating health professionals in the Americas. The current global context requires specialized individuals who are able to analyze problems and propose empirically-based solutions and/or strategies for national and international audiences. The majority of the countries in Latin America and in the Caribbean do not have a cadre of professionals with scientific knowledge and research experience regarding drug use and related issues. These assets are important when conducting work for national drug commissions, research centers, or academy. Further, many countries have not yet to establish programs or long-term plans for the development of research on the drug phenomenon, and have failed to incorporate large-scale results in the development of national drug control policies. As a solution, low and middle income countries have partnered with developed countries to design strategies for professional advancement in the study of the drug phenomenon. International organizations have collaborated with their member states on strengthening institutional capacity and human resources in relation to issues stemming from the drug phenomenon, including security, money-laundering and drug demand reduction.

4 International research capacity building program for health... Specifically, in the region of the Americas, 94% of countries offered training pertaining to drug demand reduction (prevention and treatment). Beneficiaries included professional and technical personnel working in areas of addiction, such as police officers, teachers, counselors, prison guards, instructors and community leaders. A diverse range of topics was made available to participants, including: awareness of, and multidisciplinary approaches to, drug addiction; appropriate program application methods for diverse populations and environments; and refresher/ advanced training in prevention and treatment. 4 Although some countries include a prevention component in the professional curricula of health and social sciences (nursing, public health, social work, etc.), other countries continue to demonstrate weaknesses in terms of accurately distinguishing between drug prevention programs and ad hoc activities or interventions. Such activities, including conferences, lectures, symposium and contests, are not part of comprehensive prevention strategies. These countries need to focus efforts on capacity-building in order to develop and deliver appropriate prevention programs that will facilitate scientific evaluations. 4 Some international organizations have developed joint initiatives regarding drug dependence treatment and care, that stress that services must address drug use disorders in a pragmatic, science-based, and humanitarian way. To do so, this initiative calls for the development of a comprehensive, health-based approach to drug policy that can reduce demand for illicit substances, relieve suffering, and decrease drug-related harm affecting multiple facets of society. 5 There are few drug research capacity-programs in the Americas that are continually offered to health professionals. One of the first research agencies to adopt a public health, evidence-based approach to drug abuse and addiction is in the United States. Since its conception in 1990, this agency has built partnerships with countries, organizations, and individual researchers to advance multinational cooperation, promote new research initiatives, expand international research capacity, and share knowledge about drug abuse and addiction. By promoting regional and global scientific networks, this organization disseminates research methods and findings around the world, whilst simultaneously introducing grantees to talented drug abuse researchers from other countries. Facilitating this collaboration encourages the discovery of evidence-based interventions, and contributes to global efforts to develop, adopt, and evaluate government policies, prevention programs, and treatment protocols that effectively address drug abuse and its consequences. 6 Following this same line of orientation, the Organization of American States (OAS), the Secretariat for Multidimensional Security (SMS) and CICAD has partnered with the CAMH since 2006 to offer the International Research Capacity-Building Program for Health and Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean. As a unique experience in the Americas, this initiative has facilitated the training of Latin American and Caribbean university researchers in advanced drug research methodology. This training enables researchers to conduct multicentric studies regarding drug related issues specifically pertaining to five programmatic areas of demand reduction: promotion of healthy and sustainable lifestyles, prevention of drug use and abuse, treatment, rehabilitation and social integration. FRAMEWORK The complexities of the drug phenomenon demand the adoption and application of a broader and holistic perspective. The national, international and global consequences of the drug problems urge each State in the hemispheric area to work together in cooperation and partnership. This calls for a framework that supports the analysis and decision making required for policy, program and project design in accordance with this new perspective. Figure 1 presents the Critical-Holistic International Health Model 7 applied to the analysis and work of the drug phenomenon. This model offers a multidimensional view, as well as a critical-holistic perspective of the interaction, integration and balance of the drug phenomenon components. According to this framework, the drug phenomenon should be seen as the interrelationship between national and international dimensions, and the ultimate impacts at a global level. 8 Therefore, the drug phenomenon is a social problem, with its determinants and conditioning factors ranging from ethical-legal, agro-ecological, cultural, spiritual, economic, political and technological aspects all of which have an impact on the health of the individual, family and community. To understand these interrelationships, it is important to consider four major concepts that affect the process of policy design and decision making: power, interest, knowledge and leadership. 9

5 The Critical-Holistic International Health Model (Figure 1) applied to the Drug Phenomenon was used as a framework to support the design and implementation of the International Research Wright MGM, Cumsille F, Padilha MI, Ventura CA, Sapag J, Brands B, et al. Capacity-Building Program for Health and Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean at CAMH, Toronto, Canada. Figure 1 - Critical-Holistic International Health Model applied to the Drug Phenomenon. USA, TECHNICAL AND FINANCIAL COOPE- RATION The new Hemispheric Drug Strategy 9 recommends the promotion of international cooperation programs among member states in order to strengthen national policies and provide technical assistance. This will allow for the exchange of best practices and lessons learned when addressing the world drug problem in regards to institutional capacity, supply and demand reduction, and control measures. The Plan of Action of the new Hemispheric Strategy 10 states that international cooperation should promote technical assistance, financing, and training to facilitate compliance with the recommendations formulated under the framework of the Multilateral Evaluation Mechanism (MEM). In addition, the strategy further expresses the need to strengthen government relationships by employing academic and research institutions to generate evidence regarding the demand for drugs. In 2005, ES/CICAD invited CAMH to collaborate on the implementation of the International Research Capacity-Building Program for Health and Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean. This was achieved through a technical and financial cooperation supported by the Government of Canada/Foreign Affairs and International Trade Canada (DFAIT). During , a pilot of the program was completed with 11 nurses and the support of the Faculty of Nursing at the University of Alberta/Canada. 11 In 1986, the CICAD was established by the General Assembly of the OAS as the Western Hemisphere s policy forum regarding all aspects of the drug phenomenon. CICAD s core mission is to enhance the human and institutional capabilities of its members to reduce the production, trafficking, and use and abuse of illegal drugs. Further, it sets out to address the health, social and criminal consequences of the drug trade. CICAD is the OAS Secretariat that: Fosters multilateral cooperation regarding drug issues in the Americas. Executes action programs to strengthen the capacity of CICAD member states in order to prevent and treat licit and illicit drug abuse; combat production of illicit drugs; deny traffickers their illegal profits. Promotes drug-related research; information exchange; specialized training; technical assistance.

6 International research capacity building program for health... Develops and recommends minimum standards for drug-related legislation and treatment; measurement of both drug consumption and the cost of drugs to society; drug-control measures. Carries out regular multilateral evaluations of progress by member states in all aspects of the drug problem (Multilateral Evaluation Mechanism). The CAMH is Canada s leading addiction and mental health institution, as well as a Pan American Health Organization (PAHO) and World Health Organization (WHO) Collaborating Centre fully affiliated with the University of Toronto. In June 2002, CAMH launched the Office of International Health (OIH) to address the growing global burden of addiction and mental illness borne by underresourced regions of the world. Since its creation, the Office of Transformative Global Health (OTGH) has been working with countries in various regions of the world including Africa, Latin America and the Caribbean (LAC), and South Asia to strengthen mental health and addiction capacity at local, regional and national levels. The International Research Capacity-Building Program for Health and Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean has been implemented at CAMH through the OTGH from 2006 to present. Educational program The purpose of the International Research Capacity-Building Program for Health and Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean is to create a cadre of health-related professionals with specialized scientific knowledge and research skills in regards to drug-related issues. These assets are to be applied at various levels, including policy design, decision making, research programs, project implementation, and management and evaluation. The aims of the program are: To strengthen the scientific knowledge and technical research skills among university faculty. To study the drug issues and related problems at the levels of policy design, decisionmaking and programs. To provide research management skills for implementation, evaluation and knowledge translation. This one year academic program consists of 1116 hours hours of on-site training in Canada, and 650 hours to conduct a multicentric research study in the countries of origin. The first portion of the program dedicates two weeks to reinforcing language skills (English and Spanish, depending on the need) and provides a review of aspects of Canadian culture. This is followed by two months of in-class training at CAMH, as well as the formulation of a multicentric research study. Program faculty consists of well known CAMH researchers and academics proficient in various areas the program. An adult education learning format is employed in order to enable learning and collaborative work with the ten participants from various countries in Latin America and the Caribbean (see Table 1). The second component of the program pertains to the implementation of the research study in the participants native countries during a period of eight and a half months. Table 1 - General Characteristics of the Education Program, Toronto, Canada, 2014 Number of hours Type of program Length Faculty Target Language Type of research Funding Association 466 hours (Part I) 650 hours (Part II) Total: 1116 hours Post doctorate (participants with PhD) Specialization (participants with MSc) 1 year, divided as follows: Part I: Theory and practice of program s content (Toronto, Canada) Part II: Distance learning tutorial (country of origin) University of Alberta, Centre for Addiction and Mental health, University of Toronto, and Inter- American Drug Control Commission Health related professionals English Multicentric research based in a central drug theme chosen with the group, along with CICAD s priorities, countries priorities and interest of participants Government of Canada (2003-present) CICAD and the University of Alberta (first edition); subsequent editions with the Centre for Addiction and Mental Health

7 The on-site training component includes seven sections: a one week pre-module to define the central theme of the multicentre study on drugs, followed by six academic modules (see Table 2): Drug issues in the Americas and in the world. International health and the drug phenomenon in the Americas and the world. Wright MGM, Cumsille F, Padilha MI, Ventura CA, Sapag J, Brands B, et al. Research methodology (qualitative and quantitative). Creation and management of research groups and research exchange programs in the Americas. Communication and dissemination of research findings. Development of research proposal. Table 2 - Academic curriculum of the program. Toronto, Canada, 2014 Modules Themes Hours (i) English language and cultural aspects of Canadian society 80 Pre-Module (ii) Seminar for selection of central research theme for multicentric drug research proposal 30 I Drug problems in the Americas and the world 20 II International health and drug phenomenon in the Americas and the world 20 III Research methodology (qualitative and quantitative) 120 IV Creation and management of research groups and research exchange programs in the Americas 20 V Communication and dissemination of multicentric research findings 16 VI Development of multicentric drug research proposal 160 VII Implementation of the multicentric research project in the country of origin 650 Total 1116 A total of twenty two countries have been represented in the program from Latin America and the Caribbean from The country with the highest representation in the program is Brazil (19); followed by Colombia (9); Jamaica (9); Nicaragua (8); Chile (7); El Salvador (5); Ecuador and Peru (4) each; Costa Rica, Guatemala, Guyana, and Mexico (3) each; Honduras, Panama, Trinidad & Tobago, and Uruguay (2) each; Argentina, Bahamas, Barbados, Belize, Paraguay, and Suriname (1) each. After the first offer in 2004, CICAD opened the program to all health related areas, and partnered with CAMH in 2006 to establish the International Research Capacity-Building Program (IRCBP). The academic areas represented in the program are: Nursing (41), Psychology (16), Medicine (13); Public Health (5); Education (4) Sociology and Social Work (2) each; Political Sciences, Statistics, Pharmacy, International Relations, and Occupational Therapy only with (1) participant each. Table 3 provides the titles of the multicentric drug studies conducted by participants in the program. Five groups of program participants chose university students as their sample population. One group examined the relationship between drugs and violence among women, one group focused on the perspectives of family and familiars of illicit drugs users; another group on treatment centers, and another group on the urban attitudes. In addition, it is important to mention that program graduates have been involved in varying capacities in other studies developed by CICAD/ EDRS, The study on Drugs, women and violence in 12 countries of the Americas influenced the implementation of two similar studies in Latin America, one of them entitled The nexus between drugs and violence in the Americas: a gender perspective (ES/CICAD/OID/CAMH/10 countries final study, in process to be implemented). The five studies related to university populations presented critical information that has yet to be addressed in the studies implemented by CICAD/ OIDS. The study on perceptions of family and familiars, Illicit grug use in Canada Toronto: critical perspectives of family and familiars was replicated in Canada by CAMH to address an evidence gap for this subject in this country. The study conducted in the treatment centers was the first multicentric study implemented in Latin America and Caribbean countries related to this subject. The study on urban attitudes is also the first multicentric study carried out in Latin America and Caribbean countries.

8 International research capacity building program for health... Table 3 - Titles of multicentric studies from of the IRCBP (Canada), Toronto, Canada, Year Program studies Women, drugs and violence in Latin America (exploratory study I) Illicit drug use in seven Latin American countries: critical perspectives of family and familiars University student s perceived norms about peers and drug use: a multicentric study from five Latin America countries Simultaneous poly-drug consumption among undergraduate university students in six Latin American countries and in one Caribbean country: gender, legal and social implications A multicentric study of comorbidity between psychological distress and drug use among patients in treatment centers, in seven countries of Latin America and one country in the Caribbean: policy and program implications Drug use among university students and its relationship with maltreatment during childhood in seven universities in Latin America and the Caribbean The role of family relations, spirituality and entertainment in moderating the relationship between peer influence and drug use among university students in five countries of Latin America and three countries in the Caribbean Knowledge of consequences, academic performance and drug consumption among undergraduate university students in six Latin America and three Caribbean countries Urban attitudes toward persons who use drugs in five Latin America and five Caribbean Countries Table 4 summarizes the achievements of the program, with a total of 91 participants from Further, it should be noted that more than 50 articles have been published in international journals, more than 40 posters have been presented at international and national conferences, and a total of 8 posters have been presented at the NIDA/NIH International Research Forum. Table 4 - Graduates and Products of IRCBP from Toronto, Canada, 2014 Graduates Products Group graduates The graduates have already published more than 50 articles in international Group graduates journals Group graduates The graduates have already presented more than 40 posters at Executive Secretariat/Inter-American Drug Control Commission/ Educational Group graduates Development Program international meetings Group graduates Eight posters were presented at National Institute on drugs abuse/ Group graduates National Institutes of Health International Research Forum ( Group graduates posters; posters; poster; poster; posters) Group in process to graduate Group in process to graduate Total 91 participants Challenges of the program Even though there are many indications of success, the program faces several challenges on an ongoing basis. A central concern has been the provision of funding for the program. The Canadian Government has generously provided funding on an annual basis, but longer-term funding commitments (e.g., for five years) would facilitate longer-term planning and permit extension of the program to address new issues. Other challenges relate to the multinational and multilingual nature of the program. Participants are drawn from Spanish, Portuguese and English-speaking countries, and communications challenges can arise when dealing with the complex theoretical and methodological considerations involved in carrying out a multinational research project. Participants may have limited experience in conducting research, and in publishing results. This limited experience may be compounded when they return to their home institutions and regular academic workloads, with a commitment to carry out the research plan within an agreed-upon time and with a very limited budget. Ethics and other approvals required at home institutions must also be met and are sometimes

9 lengthy. Finally, communications among investigators are necessary at different stages of the projects, typically involving ing, and this can be slow because of the varying academic demands and schedules of investigators. Impact of the program In spite of the challenges that have been encountered in implementing and carrying out the program, it has achieved remarkable success on several fronts. The program has identified and fostered a group of exceptionally talented and committed faculty from Latin American and the Caribbean, and furthered their engagement in research on the drug phenomenon in the region. Several of these individuals have pursued advanced research and professional training in Latin America and the Caribbean, North America and Europe and have been successful in obtaining very competitive fellowship support for this advanced training. In addition, the program has led to substantial research productivity in terms of presentations at national and international conferences and publications in international journals. 12 A cadre of active researchers on drug issues and demand reduction has been created in Latin America and the Caribbean. Ongoing linkages and interactions among these researchers are being facilitated by the Latin American Network of Researchers on Drugs and the newly-formed IRCBP Alumni Association. The existence of this cadre of researchers also creates important opportunities for a Pan-American network of drug researchers to facilitate knowledge transfer and effective policy and program interventions, and to develop international programs of research. Many participants have also taken on academic leadership positions at their home institutions and in national drug commissions. Additionally, graduates have strengthened the drug-related aspects of undergraduate, graduate and professional programs in their home institutions, and have held leadership roles in CICAD-led initiatives to strengthen educational and professional programs across the region. External evaluation of the program In 2012, CICAD/OAS hired an external evaluator to conduct a complete evaluation of the program. The findings from the evaluation indicated that 99% of the participants have been able to comply with all the requirements of the program Wright MGM, Cumsille F, Padilha MI, Ventura CA, Sapag J, Brands B, et al. (graduation, communication and dissemination of the research findings and publications). It also indicated the International Research Capacity-Building Program (IRCBP) is highly relevant in helping to satisfy an acknowledged need for evidence-based research in Latin America and the Caribbean. FINAL CONSIDERATIONS In a relatively short period of time, the International Research Capacity-Building Program for Health and Related Professionals to Study the Drug Phenomenon in Latin America and the Caribbean has achieved some exceptional successes. The program has built lasting international links among drug researchers in South/Central America, the Caribbean and North America. Several ambitious multinational research projects have contributed substantially to our understanding of drug issues in LAC countries. Thus, the program has achieved and exceeded its goals, and continuation of the program will further serve the important purpose of increasing the research capacity necessary to implement and support effective drug demand reduction programs and policies in Latin America and the Caribbean, and in the Americas more generally. Nevertheless, important challenges remain. The most critical is the need to obtain stable, multiyear funding to support the program. Additionally, expanding the capability of the program to support new multicentric studies by program alumni would be a very significant advance, and provide an important next step in creating and maintaining the research capacity necessary for effective efforts to address the drug phenomenon in the Americas. Acknowledgment OAS/SMS/CICAD-CAMH would like to express our sincerely thanks to the Government of Canada/Foreign Affairs and International Trade Canada for its continuing financial support to the program; to all Universities and National Drug Commissions authorities, and families of the participants for their collaboration, support and understanding of the importance and value of the program; to all faculty and advisors for their time, collaboration, and support to make this program to exceed its academic and scientific contribution to the study of the drug phenomenon in Latin America and the Caribbean; to all participants of the program to accept the challenges the program

10 International research capacity building program for health... imposes; to the Coordinators and Administrative personnel of the program for their continued collaboration, dedication, and support to make this program possible and successful, and finally to all population samples who participated in the different multicentric drug studies implemented by the participants of the program. REFERENCES 1. United Nations Office on Drugs and Crime. World Drug Report. Vienna: UNODC; Organization of American States, Secretary for Multidimensional Security, Interamerican Drug Control Abuse Commission. Hemispheric drug strategy. Washington (DC): OAS; Latin American Commission on Drugs and Democracy. Drugs and democracy: toward a paradigm shift [online] [access 2012 Apr 10]. Available at: Arquivos/declaração_Ingles_site.pdf 4. Organization of American States, Secretariat for Multidimensional Security, Interamerican Drug Control Abuse Commission. Multilateral evaluation mechanism. hemispheric report. Washington (DC): OAS; United Nations Office on Drugs and Crime, World Health Organization. Programme on drug dependence treatment and care [access 2012 Apr 10]. Available at: treatment/unodc _WHO_ programme _ brochure _ English.pdf 6. National Institute of Health, National Institute of Drug Addiction. NIDA International Program [access 2012 Apr 10]. Available at: gov/guide/pa-files/pa html. 7. Wright MGM. A Critical-Holistic Paradigm for an Interdependent World. Am Behav Scient. 2000; 43(5): Wright MGM. La contribución de la enfermería frente al fenómeno de las drogas y la violencia en América Latina: un proceso en construcción. Ciencia Enferm. 2002; 8(2): Organization of American States, Interamerican Drug Control Abuse Commission. The Role of nursing profession and the drug phenomenon in Latin America. Washington (DC)/Florianópolis (SC): OAS/Universidade Federal de Santa Catarina; Organization of American States, Secretary for Multidimensional Security, Interamerican Drug Control Abuse Commission. Hemispheric drug strategy: plan of action Washington (DC): OAS; Wright MGM, Caufield C, Gray G, Olson J. International research capacity-building programs for nurses to study the drug phenomenon in Latin America: challenges and perspectives. Rev Latino- Am Enfermagem. 2005; 13(2): Wright MGM, Cumsille F, Khenti A, Padilha MI. Editorial. Texto Contexto Enferm Jan-Mar; 21(Special):11-2. Corresponding Author: Akwatu Khenti Transformative Global Health Office Centre for Addiction and Mental Health Toronto, Canada akwatu.khenti@camh.ca

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D. Akwatu Kenthi, MA Centre for Addictions and Mental Health CAMH

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D. Akwatu Kenthi, MA Centre for Addictions and Mental Health CAMH INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FORTY-EIGHTH REGULAR SESSION December 6-8, 010 Washington, D.C. OEA/Ser.L/XIV..48 CICAD/doc.187/10 3 December

More information

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE Washington, D.C., USA, 27 September-1 October 2010 Agenda Item 4.17 27 September

More information

SKILLS AND CURRICULUM AT LAW CAREERS WITH THE CONTENT OF DRUGS: THE EXPERIENCE OF THE SE / CICAD IN LATIN AMERICA

SKILLS AND CURRICULUM AT LAW CAREERS WITH THE CONTENT OF DRUGS: THE EXPERIENCE OF THE SE / CICAD IN LATIN AMERICA Reunión CICAD Meeting de la CICAD with con Universities Universidades of the de Americas las Américas on the sobre Drug el Fenómeno de Phenomenon las Drogas desde from the la Perspectiva Perspective de

More information

Hemispheric Report. evaluation report on Drug control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Hemispheric Report. evaluation report on Drug control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG AbUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITy (SMS) evaluation report on Drug

More information

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American / World Outline Facts and Figures Suicide a major Public problem Suicide in the Americas Risk and Protective factors and related interventions

More information

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Executive Board of the United Nations Development Programme and of the United Nations Population Fund United Nations DP/FPA/CPD/BRA/4 Executive Board of the United Nations Development Programme and of the United Nations Population Fund Distr.: General 9 October 2006 Original: English UNITED NATIONS POPULATION

More information

CICAD Meeting with the Universities of the Americas Concerning the Drug Phenomenon Focusing on the Use of Scientific Evidence

CICAD Meeting with the Universities of the Americas Concerning the Drug Phenomenon Focusing on the Use of Scientific Evidence CICAD Meeting with the Universities of the Americas Concerning the Drug Phenomenon Focusing on the Use of Scientific Evidence THE ROLE OF FAMILY RELATIONS, SPIRITUALITY AND ENTERTAINMENT IN MODERATING

More information

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI 2 Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making

More information

ORGANIZATION OF AMERICAN STATES

ORGANIZATION OF AMERICAN STATES ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 OEA/Ser.L/XIV.4 CICAD/EULAC/doc.39pp/08

More information

CICAD. Report on Drug Use in the Americas Executive Summary INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION

CICAD. Report on Drug Use in the Americas Executive Summary INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD SIXTY-FOURTH REGULAR SESSION November 19-21, 2018 Washington D.C., USA OEA/Ser.L/XIV.2.64 CICAD/doc. 2435/18 November 20 2018 Original: English Report

More information

Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES

Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES References to Brazil Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Cocaine In 2010, the regions with a high

More information

B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY

B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY Page 7 B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY Background 1. Member States approved the Pan American Health Organization s (PAHO) Gender Equality Policy during the 46th Directing

More information

Expert consultation on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ)

Expert consultation on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ) Expert consultation on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ) UNODC Concept Note Background Strengthening the production, collection, dissemination and analysis

More information

TERMS OF REFERENCE. Comparative evaluation of FOKUS projects on violence against women

TERMS OF REFERENCE. Comparative evaluation of FOKUS projects on violence against women TERMS OF REFERENCE Comparative evaluation of FOKUS projects on violence against women 1. BACKGROUND FOKUS Forum for Women and Development is a knowledge and resource center for international women s issues

More information

WORLD HEALTH ORGANIZATION

WORLD HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB115/29 115th Session November 2004 Provisional agenda item 4.15 International Plan of Action on Ageing: report on implementation Report by the Secretariat 1.

More information

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009. B. UPDATE ON THE PANDEMIC (H1N1) 2009 CD50/INF/6 (Eng.) - 7 - Annex B Background 20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus

More information

HEMISPHERIC PLAN OF ACTION ON DRUGS

HEMISPHERIC PLAN OF ACTION ON DRUGS INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD SECRETARIAT FOR MULTIDIMENSIONAL SECURITY HEMISPHERIC PLAN OF ACTION ON DRUGS 2016-2020 HEMISPHERIC STRATEGY ON DRUGS INTRODUCTION In the Americas the

More information

CICAD INTER AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security

CICAD INTER AMERICAN DRUG ABUSE CONTROL COMMISSION. Secretariat for Multidimensional Security INTER AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security FORTY NINTH REGULAR SESSION May 4 6, 2011 Paramaribo, Suriname OEA/Ser.L/XIV.2.49 CICAD/doc.1860/11 rev.2 corr.

More information

Senior Management Team Meeting Target setting in Latin America

Senior Management Team Meeting Target setting in Latin America Senior Management Team Meeting Target setting in Latin America October 2006 Nancy Andrade-Castro RST Latin America Geneva/2006 For all enquiries, please contact Nancy Andrade-Castro, Acting Director for

More information

References to Uruguay

References to Uruguay References to Uruguay Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Regional trends in illicit drug use South

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Paraguay 2005 PROGRESS REPORT IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information

Saint Kitts and Nevis. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD

Saint Kitts and Nevis. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD 1 9 9 9 2 0 0 0 M u l t i l a t e ra l E v a l u a t i o n M e c h a n i s m M E M Saint Kitts and Nevis Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD M EM 1 9

More information

Prevalence of Marijuana Use among University Students in Bolivia, Colombia, Ecuador, and Peru

Prevalence of Marijuana Use among University Students in Bolivia, Colombia, Ecuador, and Peru Int. J. Environ. Res. Public Health 2015, 12, 5233-5240; doi:10.3390/ijerph120505233 OPEN ACCESS Article International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations DP/FPA/CPD/BRA/5 Executive Board of the United Nations Development Programme, the United Nations Population Fund the United Nations Office for Project Services Distr.: General 26 September

More information

HEMISPHERIC PLAN OF ACTION ON DRUGS,

HEMISPHERIC PLAN OF ACTION ON DRUGS, 1 HEMISPHERIC PLAN OF ACTION ON DRUGS, 2016-2020 HEMISPHERIC DRUG STRATEGY - PLAN OF ACTION, 2016-2020 OAS Cataloging-in-Publication Data Inter-American Drug Abuse Control Commission. Hemispheric Plan

More information

Expert consultation on the improvement of drug statistics and to strengthen the Annual Report Questionnaire (ARQ) UNODC Concept Note

Expert consultation on the improvement of drug statistics and to strengthen the Annual Report Questionnaire (ARQ) UNODC Concept Note Expert consultation on the improvement of drug statistics and to strengthen the Annual Report Questionnaire (ARQ) UNODC Concept Note 6 June, 2017 Background Strengthening the production, collection, dissemination

More information

References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS

References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Cocaine In 2010, the regions with a

More information

Economic and Social Council

Economic and Social Council United Nations E/CN.3/2018/22 Economic and Social Council Distr.: General 14 December 2017 Original: English Statistical Commission Forty-ninth session 6 9 March 2018 Item 4 (b) of the provisional agenda*

More information

Influenza Vaccine Use In the Americas

Influenza Vaccine Use In the Americas Influenza Vaccine Use In the Americas Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-i Alba Maria Ropero-Alvarez Comprehensive Family Immunization Unit PAHO/FGL/IM Global Vaccine and

More information

UNODC/HONLAF/26/CRP.1

UNODC/HONLAF/26/CRP.1 8 September 2016 English only Twenty-sixth Meeting of the Heads of National Drug Law Enforcement Agencies, Africa Addis Ababa, 19-23 September 2016 Item 5 (c) of the provisional agenda * Best practices

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID

More information

Zika virus (ZIKV) Latin America & Caribbean Situation Report #11 15 February 2017

Zika virus (ZIKV) Latin America & Caribbean Situation Report #11 15 February 2017 UNICEF/Ecuador/2016 Zika virus (ZIKV) Latin America & Caribbean Situation Report #11 15 February 2017 UNICEF/LACRO RESPONSE HIGHLIGHTS UNICEF has worked with government and non-government partners to ensure

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Saint Lucia 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information

Championing Health: Sustainable Development and Equity. PAHO Strategic Plan

Championing Health: Sustainable Development and Equity. PAHO Strategic Plan Championing Health: Sustainable Development and Equity PAHO Strategic Plan 2014-2019 PAHO Strategic Plan 2014-2019 While we celebrate important achievements, we recognize that much remains to be accomplished.

More information

Public health dimension of the world drug problem

Public health dimension of the world drug problem SEVENTIETH WORLD HEALTH ASSEMBLY A70/29 Provisional agenda item 15.3 27 March 2017 Public health dimension of the world drug problem Report by the Secretariat 1. The Executive Board at its 140th session

More information

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative http://www.paho.org/provac Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative Cara Bess Janusz Immunization, PAHO 1 st Regional Dengue Symposium 3-4 November

More information

CICAD expresses its satisfaction at the completion of this recommendation.

CICAD expresses its satisfaction at the completion of this recommendation. RECOMMENDATION 1: SIGN AND RATIFY THE PROTOCOL TO THE UNITED NATIONS CONVENTION AGAINST TRANSNATIONAL ORGANIZED CRIME AGAINST THE ILLICIT MANUFACTURING OF AND TRAFFICKING IN FIREARMS, THEIR PARTS AND COMPONENTS,

More information

Nicaragua. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Nicaragua. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITY (SMS) Evaluation Report on Drug

More information

Current Status in Latin America

Current Status in Latin America WHO International Consultation 15 to 17 October 2014 Munich, Germany JUSTIFICATION OF THE USE OF CT FOR INDIVIDUAL HEALTH ASSESSMENT OF ASYMPTOMATIC PEOPLE Current Status in Latin America Gloria Soto Giordani

More information

Violence against women and girls in LAC and recent health system mandates

Violence against women and girls in LAC and recent health system mandates Violence against women and girls in LAC and recent health system mandates ALESSANDRA GUEDES Regional Advisor, Family Violence PAHO/WHO, Washington, DC December 5, 2016 Outline of the presentation Violence

More information

Trinidad and Tobago ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD)

Trinidad and Tobago ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITY (SMS) Trinidad and Tobago Evaluation

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2201/15 27

More information

THE EVOLUTION OF THE ROLE OF WOMEN IN SPAIN, THE U.S., LATIN AMERICA AND THE CARIBBEAN PRESS RELEASE

THE EVOLUTION OF THE ROLE OF WOMEN IN SPAIN, THE U.S., LATIN AMERICA AND THE CARIBBEAN PRESS RELEASE 2011 THE EVOLUTION OF THE ROLE OF WOMEN IN SPAIN, THE U.S., LATIN AMERICA AND THE CARIBBEAN PRESS RELEASE For Immediate Release May 5, 2011 Contact person: Jimena Paz Cultural Projects Officer Embassy

More information

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009 Regional Update Pandemic (H1N1) 2009 (September 04, 2009-22 h GMT; 17 h EST) Update on the Qualitative Indicators For Epidemiological Week 34 (EW 34), from 23 August to 29 August, 20 countries reported

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security SIXTY-SECOND REGULAR SESSION 13-15 December, 2017 Washington, D.C. OEA/Ser.L/XIV.2.62 CICAD/doc.2325/17rev2

More information

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages 2017 highlights Hepatitis B and C in the Spotlight: A public health response in the Americas Key Messages Regarding the national structures developed to support the response to the viral hepatitis epidemics,

More information

CONFLICTS OF INTEREST RELATED TO ALCOHOL POLICY: WHAT CAN BE DONE?

CONFLICTS OF INTEREST RELATED TO ALCOHOL POLICY: WHAT CAN BE DONE? CONFLICTS OF INTEREST RELATED TO ALCOHOL POLICY: WHAT CAN BE DONE? Dr Maristela G. Monteiro Senior Advisor on Alcohol Pan American Health Organization monteirm@paho.org THE ALCOHOL INDUSTRY Globalization

More information

REPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES

REPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES REPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES ON DRUGS SEPTEMBER 13 TO 16, 2011 Kapok Hotel Port of Spain, Trinidad and Tobago The fourth biennial meeting of Caribbean National

More information

Saint Vincent and the Grenadines

Saint Vincent and the Grenadines ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITY (SMS) Saint Vincent and the

More information

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people teady Ready Go y Ready Preventing HIV/AIDS in young people Go Steady Ready Go! Evidence from developing countries on what works A summary of the WHO Technical Report Series No 938 Every day, 5 000 young

More information

Translating Science to end HIV in Latin America and the Caribbean

Translating Science to end HIV in Latin America and the Caribbean Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP

More information

Intervention from the World Health Organization

Intervention from the World Health Organization Thematic discussion on the implementation of the UNGASS outcome document Operational recommendations on Demand reduction and related measures, including prevention and treatment, as well as other health-related

More information

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009 Regional Update Pandemic (H1N1) 2009 (September 18, 2009-22 h GMT; 17 h EST) Update on the Qualitative Indicators For Epidemiological Week 36 (EW 36), from 6 September to 12 September, 17 countries reported

More information

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015 Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015 Ana F. Carvalho, MBA, MPH Director, Special Projects Vaccine Advocacy and Education Presented by: Jacqueline Lim

More information

Overview of the ProVac Initiative

Overview of the ProVac Initiative Overview of the ProVac Initiative Updated Dec. 2017 Goal of the ProVac Initiative Strengthen evidence-based decision making on immunization to sustain and further the public health impact of immunization

More information

Commission on Narcotic Drugs

Commission on Narcotic Drugs Commission on Narcotic Drugs Topic A: Implementation of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem

More information

Presidential Determination -- Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2017

Presidential Determination -- Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2017 Obama Admits Mexico and Red China Play Major Roles in International Narcotics Trafficking to the United States The White House Office of the Press Secretary For Immediate Release September 12, 2016 Presidential

More information

ORGANIZATION OF AMERICAN STATES (OAS)

ORGANIZATION OF AMERICAN STATES (OAS) ORGANIZATION OF AMERICAN STATES (OAS) Inter-American Drug Abuse Control Commission (CICAD) MULTILATERAL EVALUATION MECHANISM (MEM) Evaluation Survey Sixth Evaluation Round Evaluation Survey Multilateral

More information

Cancer prevention and control in the context of an integrated approach

Cancer prevention and control in the context of an integrated approach SEVENTIETH WORLD HEALTH ASSEMBLY A70/A/CONF./9 Agenda item 15.6 25 May 2017 Cancer prevention and control in the context of an integrated approach Draft resolution proposed by Brazil, Canada, Colombia,

More information

42nd DIRECTING COUNCIL 52nd SESSION OF THE REGIONAL COMMITTEE

42nd DIRECTING COUNCIL 52nd SESSION OF THE REGIONAL COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 42nd DIRECTING COUNCIL 52nd SESSION OF THE REGIONAL COMMITTEE Washington, D.C., 25-29 September 2000 Provisional Agenda Item 4.7 CD42/11 (Eng.)

More information

I. INSTITUTIONAL STRENGTHENING/NATIONAL ANTI-DRUG STRATEGY

I. INSTITUTIONAL STRENGTHENING/NATIONAL ANTI-DRUG STRATEGY I. INSTITUTIONAL STRENGTHENING/NATIONAL ANTI-DRUG STRATEGY In November 2000, the principal authorities initiated the implementation of the National Anti-Drug Master Plan for a five-year period. The Plan

More information

March of Dimes Global Programs. First Capability Workshop Trolleholm, Sweden 8 May 2007

March of Dimes Global Programs. First Capability Workshop Trolleholm, Sweden 8 May 2007 March of Dimes Global Programs First Capability Workshop Trolleholm, Sweden 8 May 2007 What My Presentation Will Cover Description of the March of Dimes Description of its Global Programs Initial activities

More information

Personnel. Women in the Secretariat. Report by the Director General

Personnel. Women in the Secretariat. Report by the Director General Board of Governors General Conference GOV/2017/39-GC(61)/19 Date: 2 August 2017 General Distribution Original: English For official use only Item 8(b)(ii) of the Board s provisional agenda (GOV/2017/33)

More information

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Jamaica 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS

More information

Special Topic. The ten leading causes of death in countries of the Americas

Special Topic. The ten leading causes of death in countries of the Americas The ten leading causes of death in countries of the Americas Table 1: Country specific information on the ten leading causes of death in broad age groups, by sex, for the latest two or three data years

More information

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST) Regional Update Pandemic (H1N1) 2009 (March 15, 2010-17 h GMT; 12 h EST) The information contained within this update is obtained from data provided by Ministries of Health of Member States and National

More information

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators Regional Update Pandemic (H1N1) 29 (August 28, 29-17 h GMT; 12 h EST) Update on the qualitative indicators For Epidemiological Week 33 (EW 33), from 16 August to 22 August, 22 countries reported updated

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 12 July 2011 Original:

More information

Joint UNODC-WHO Action Programme On Drug Dependence Treatment

Joint UNODC-WHO Action Programme On Drug Dependence Treatment Joint UNODC-WHO Action Programme On Drug Dependence Treatment Scaling Up Evidence-Based Services For Drug Dependence Treatment And Care 2009-2013 Draft 18 November 2008 1. BACKGROUND AND SIGNIFICANCE Substance

More information

Government of Malawi. SUMMARY of the National Plan of Action to Combat Gender-Based Violence in Malawi

Government of Malawi. SUMMARY of the National Plan of Action to Combat Gender-Based Violence in Malawi Government of Malawi SUMMARY of the National Plan of Action to Combat Gender-Based Violence in Malawi 2014 2020 Ministry of Gender, Children, Disability and Social Welfare Private Bag 330, Lilongwe 3 JULY

More information

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN 525 Twenty-third Street, N.W. Washington, D.C. 20037 1 2 In response to the high incidence

More information

Chile. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Chile. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITY (SMS) Evaluation Report on Drug

More information

ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) ( ) IMPLEMENTATION MATRIX

ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) ( ) IMPLEMENTATION MATRIX ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) (2013-2017) IMPLEMENTATION MATRIX Outcomes and Outputs Performance Indicators Means of Verification Assumptions/Risks Goal: Improve the

More information

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex. Council of the European Union Brussels, 26 November 2015 (OR. en) 14395/15 SAN 391 NOTE From: To: Subject: General Secretariat of the Council Permanent Representatives Committee/Council Employment, Social

More information

NATIONAL COMMITTEE ON AIDS, DRUGS AND PROSTITUTE CONTROL OF VIETNAM

NATIONAL COMMITTEE ON AIDS, DRUGS AND PROSTITUTE CONTROL OF VIETNAM NATIONAL COMMITTEE ON AIDS, DRUGS AND PROSTITUTE CONTROL OF VIETNAM CEREMONY FOR THE PUBLIC ANNOUNCEMENT OF THE STRATEGY ON PREVENTING, COMBATING AND CONTROLLING DRUG ABUSE IN VIETNAM TILL 2020 AND ORIENTATION

More information

I. INSTITUTIONAL BUILDING / NATIONAL ANTI-DRUG STRATEGY

I. INSTITUTIONAL BUILDING / NATIONAL ANTI-DRUG STRATEGY I. INSTITUTIONAL BUILDING / NATIONAL ANTI-DRUG STRATEGY Honduras has a National Anti-Drug Plan, approved on November 9, 2000, and in effect from January 1, 2001 till December 31, 2004, that is in the implementation

More information

Commonwealth Secretariat

Commonwealth Secretariat Commonwealth Secretariat Commonwealth Health Ministers Meeting Geneva, Switzerland, 15 May 2011 Theme: Non-Communicable Diseases A Priority for the Commonwealth Agenda Item V HMM(G)(11)4 PROGRESS REPORT:

More information

Barbados. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Barbados. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITY (SMS) Evaluation Report on Drug

More information

Multisectoral action for a life course approach to healthy ageing

Multisectoral action for a life course approach to healthy ageing SIXTY-SEVENTH WORLD HEALTH ASSEMBLY Provisional agenda item 14.4 21 March 2014 Multisectoral action for a life course approach to healthy ageing 1. The attached document EB134/19 was considered and noted

More information

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network Strategic Operational Research Plan 2017-2018 February 13, 2017 Digestive Health Strategic Clinical Network DH SCN Strategic Operational Plan The of the Digestive Health Strategic Clinical Network The

More information

Presentation by Yvonne Lewis Director Health Education Division

Presentation by Yvonne Lewis Director Health Education Division Presentation by Yvonne Lewis Director Health Education Division Cabinet Appointed Mechanism for multi-sectoral action on NCDs and an all of Government and civil society approach to population health and

More information

Eurasian Harm Reduction Association (EHRA) Strategic Framework

Eurasian Harm Reduction Association (EHRA) Strategic Framework Eurasian Harm Reduction Association (EHRA) Strategic Framework 2018-2019 What is Eurasian Harm Reduction Association (EHRA)? 2 How does strategic framework work? 2 Harm reduction, current context 3 EHRA

More information

National Drug Control Budget Executive Summary, Fiscal Year 2002

National Drug Control Budget Executive Summary, Fiscal Year 2002 National Drug Control Budget Executive Summary, Fiscal Year 2002 ONDCP April 9, 2001 I. EXECUTIVE SUMMARY Overview The FY 2002 National Drug Control Budget supports the five goals and 31 objectives of

More information

Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators

Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators Regional Update Pandemic (H1N1) 2009 (August 14, 2009-17 h GMT; 12 h EST) Update on the Qualitative Indicators For epidemiological week 31 (EW 31, August 2 to August 8) 17 countries have reported updated

More information

Identifying Common Ground on Public Health for UNGASS 2016:

Identifying Common Ground on Public Health for UNGASS 2016: Identifying Common Ground on Public Health for UNGASS 2016: What does a public health approach to global drug policy mean in practice? 21 April 2015, United Nations Headquarters Concept Note As momentum

More information

João Goulão, MD. EVIDENCE-BASED POLICIES 21 April April João Goulão

João Goulão, MD. EVIDENCE-BASED POLICIES 21 April April João Goulão INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security DRUGS SUMMIT EUROPEAN, LATIN AMERICAN AND CARIBBEAN MAYORS AND CITIES April 21 23, 2010 Lugo, Spain OEA/Ser.L/XIV.4.1

More information

Jamaica. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Jamaica. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITY (SMS) Evaluation Report on Drug

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-SECOND REGULAR SESSION November 28-30, 2012 San José, Costa Rica OEA/Ser.L/XIV.2.52 CICAD/doc.1979/12

More information

C a n a d a. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD

C a n a d a. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD 1 9 9 9 2 0 0 0 M u l t i l a t e ra l E v a l u a t i o n M e c h a n i s m M E M C a n a d a Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD M EM 1 9 9 9 2 0 0

More information

Taking vaccine effectiveness into public health decision making: The ProVac Example

Taking vaccine effectiveness into public health decision making: The ProVac Example http://www.paho.org/provac Taking vaccine effectiveness into public health decision making: The ProVac Example Evaluating dengue effectiveness workshop June 12 th, 2014 Washington, DC Cara Bess Janusz

More information

Cervical Cancer Situation in Latin America and the Caribbean and PAHO/WHO Recommendations for the Way Forward

Cervical Cancer Situation in Latin America and the Caribbean and PAHO/WHO Recommendations for the Way Forward Cervical Cancer Situation in Latin America and the Caribbean and PAHO/WHO Recommendations for the Way Forward Silvana Luciani Advisor, chronic disease prevention and control project Pan American Health

More information

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST) Regional Update Pandemic (H1N1) 9 (July 19, - 17 h GMT; 12 h EST) The information contained within this update is obtained from data provided by Ministries of Health of Member States and National Influenza

More information

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward SARInet annual meeting, Punta Cana, May 23 2017 Nathalie El Omeiri On behalf of REVELAC-i network, Alba

More information

48th DIRECTING COUNCIL 60th SESSION OF THE REGIONAL COMMITTEE

48th DIRECTING COUNCIL 60th SESSION OF THE REGIONAL COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 48th DIRECTING COUNCIL 60th SESSION OF THE REGIONAL COMMITTEE Washington, D.C., USA, 29 September-3 October 2008 Provisional Agenda Item 4.13

More information

Council of the European Union Brussels, 28 October 2015 (OR. en)

Council of the European Union Brussels, 28 October 2015 (OR. en) Conseil UE Council of the European Union Brussels, 28 October 2015 (OR. en) PUBLIC 13261/15 LIMITE SAN 347 NOTE From: To: Subject: General Secretariat of the Council Working Party on Public Health Draft

More information

Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders

Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders 1. An electronic survey was administered in April-May 2013 to 112 World Bank Task Team Leaders of Bank-supported health projects

More information

ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH

ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH Michal Krzyzanowski WHO ECEH Bonn Office 1 Exposure - Response Population X Exposure IMPACT ESTIMATE FOR POPULATION X Population X health status WHO Air

More information

Federation of Saint Kitts and Nevis

Federation of Saint Kitts and Nevis Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Federation of Saint Kitts and Nevis 2009 EVALUATION OF PROGRESS IN DRUG CONTROL

More information

Honduras. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Honduras. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITY (SMS) Evaluation Report on Drug

More information